Previous 10 | Next 10 |
– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing – – Company targets initiating preclinical Investigational New Drug ( IND) enabling studies in Q1 2021 – MORRISVILLE, N....
Robinhood Penny Stocks To Watch Next Week In December 2020, there are plenty of options when it comes to penny stocks to watch . While these cheap stocks are quite volatile, there are ways that traders can use this volatility to their advantage. One of the best ways to start finding...
– Completion of patient enrollment targeted for Q1 2021 with readout of topline results targeted for Q2 2021 – – SB206, if approved, has the potential to meet an important need for the treatment of molluscum, an area with no current FDA-approved treatment ...
Which Penny Stocks Should You Know About Heading Into 2021? As we inch closer to the end of a tumultuous year, there are many penny stocks to watch. During 2020, the COVID pandemic has made several penny stocks jump up greatly in value. While not all penny stocks are correlated with...
Looking For Top Penny Stocks To Buy Right Now? Start With A Watch List In the past few weeks, investors have seen a great deal of bullish interest in penny stocks . This is not to say all penny stocks have had bull runs, but rather a select group. There are several factors curre...
Why Are These Penny Stocks Gaining Attention In December 2020? As 2020 comes to a close, there are plenty of penny stocks to watch . While finding penny stocks may seem like a daunting task at first, it can be made much easier with a few simple tips. The first tip that all inve...
The Nasdaq has approved Novan's (NOVN) request to transfer its listing to the Nasdaq Capital Market from Nasdaq Global Market, effective November 5, 2020.Trading on Nasdaq Capital Market is expected to begin on November 5, 2020. On transfer, Nasdaq granted the Company its second grace period ...
– T rading on Nasdaq Capital Market is expected to begin on November 5, 2020 – – Company receives additional 180-day grace period, until May 3, 2021, to satisfy the $1.00 bid price requirement to maintain Nasdaq listin...
Novan (NOVN): Q3 GAAP EPS of -$0.06 in-line.Revenue of $1.32M (flat Y/Y) beats by $0.08M.Cash and cash equivalents of $43.1MPress Release For further details see: Novan EPS in-line, beats on revenue
– Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 – – First to demonstrate antiviral effect of nitric oxide-based medicine against SARS-CoV-2 in an in ...
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...